Greatview Aseptic Packaging (468) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
1 Dec, 2025Executive summary
Revenue for the first half of 2024 declined 13.9% year-over-year to RMB1,627.3 million, mainly due to lower sales volume amid intensified competition and a pressured dairy market in China and internationally.
Net profit increased 17.7% year-over-year to RMB117.5 million, driven by improved gross margin and cost control.
Gross margin rose to 20.3% from 15.7% in the prior year period, reflecting better product mix and efficiency.
The company sold approximately 9.0 billion packs, a 14.5% decrease from the same period last year, due to intensified market competition.
No interim dividend was declared for the period.
Financial highlights
Revenue: RMB1,627.3 million (down 13.9% year-over-year).
Gross profit: RMB330.1 million (up 11.1% year-over-year).
Net profit: RMB117.5 million (up 17.7% year-over-year).
Basic and diluted EPS: RMB0.084 (up from RMB0.075 year-over-year).
Cash and cash equivalents: RMB780.3 million as of 30 June 2024.
Outlook and guidance
Plans to deepen cooperation with existing customers, expand market share in China, and pursue international growth through localized operations and new product development.
Focus on technological innovation, sustainability, and digital transformation to enhance competitiveness.
Continued emphasis on operational excellence, cost control, and quality.
Latest events from Greatview Aseptic Packaging
- Net profit plunged 91.7% on lower sales and margins, with trading suspension and legal risks ongoing.468
H1 2026 - Sharp profit decline, restructuring, and internal control issues drive major remedial actions.468
H2 2025 - Net profit fell 32.4% on lower margins; trading remains suspended after major shareholding change.468
H1 2025 - Revenue and profit plunged amid governance overhaul, investigations, and trading suspension.468
H2 2024